NVGN Key Stats
SA Breaking News01/16 09:11
SA Breaking News01/15 12:45
SA Breaking News01/15 10:31
PR Newswire01/15 10:00
PR Newswire01/07 10:00
SA Breaking News01/07 07:10
SA Breaking News12/22 09:17
PR Newswire12/19 10:00
SA Breaking News12/19 09:11
NVGN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Novogen is down 43.10% over the last year vs S&P 500 Total Return up 14.34%, Auspex Pharmaceuticals up N/A, and Tetraphase Pharmaceutical up 128.1%.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for NVGN
Portfolio Strategies Featuring NVGN
Did Novogen make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Company Website: http://www.novogen.com
- IR Website: http://www.novogen.com/annual-reports
- HQ Country: Australia
- HQ State/Province: N/A
- Incorporation Country: Australia
- Incorporation State/Province: N/A
- Est. Current Fiscal Quarter End: March 31, 2015
- Est. Current Fiscal Year End: June 30, 2015
- Last Fiscal Quarter End: June 30, 2014
- Last Fiscal Year End: June 30, 2014
- Next Earnings Release: N/A
Novogen Ltd is in the early stage of drug development.
NVGN Excel Add-In Codes
- Name: =YCI("NVGN","name")
- Description: =YCI("NVGN","description")
- Sector: =YCI("NVGN","sector")
- Industry: =YCI("NVGN","industry")
- Est. Current Fiscal Year End: =YCI("NVGN","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.